Madrigal Pharmaceuticals ...

NASDAQ: MDGL · Real-Time Price · USD
369.75
-1.62 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
344.50
-6.83%
After-hours: Aug 15, 2025, 07:58 PM EDT

Madrigal Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-281.9M -391.59M -465.89M -518.67M -510.45M -444.27M -373.63M -347.34M -329.8M -314.73M -295.35M -273.99M -255.9M -246.82M -241.85M -236.42M -231.28M -218.66M
Depreciation & Amortization
1.47M 1.36M 1.1M 875K 712K 571K 527K 514K 500K 484K 467K 444K 420K 399K 405K 415K 433K 459K
Stock-Based Compensation
81.66M 80.91M 79.88M 77.06M 71.82M 58.39M 49.73M 42.97M 38.43M 35.4M 31.63M 29.9M 28.02M 28.25M 26.87M 25.65M 24.47M 21.98M
Other Working Capital
-11.24M 2.83M -13K 17.57M 8.92M -10.19M 11.49M 20.08M 25.04M 48.23M 35.15M 20.62M 16.17M 9.38M 10.29M 15.4M 17.21M 22.45M
Other Non-Cash Items
-9.93M 2.71M 72.98M 76.83M 77.49M 38.88M 6.05M 1.97M 1.61M 1.23M 7.09M 37.43M 34.2M 45.71M 42.37M 35.2M 38.11M 26.43M
Deferred Income Tax
n/a n/a n/a -3.64M -3.64M -3.64M -3.64M n/a n/a n/a n/a -30.65M -30.65M -30.65M -30.65M -23.48M -23.48M -23.48M
Change in Working Capital
-111.02M -87.46M -72.34M 7.82M -13.59M -6.64M -3.28M -917K 12.3M 18.61M 37.6M 28.77M 26.4M 27.76M 30.65M 19.54M 13.27M 25.73M
Operating Cash Flow
-307.41M -395.31M -455.57M -431.02M -448.95M -389.32M -324.23M -302.81M -276.96M -259.01M -224.86M -214.39M -200.88M -190.4M -183.92M -190.81M -193.11M -170.48M
Capital Expenditures
-974K -6.11M -6.46M -7.3M -6.86M -1.8M -1.48M -472K -166K -200K -217K -301K -318K -217K -209K -106K -59K -64K
Cash Acquisitions
n/a n/a n/a 361.09K 310.55K 314.21K -1.85M -2.22M -2.23M -2.26M 18.49K 808.49K 873.66K 893K 1.27M 2.4M 2.4M 2.4M
Purchase of Investments
-1.12B -1.18B -1.13B -1.26B -908.73M -719.81M -834.44M -372.33M -317.68M -304.73M -143.48M -185.44M -286.55M -337.96M -394.12M -455.53M -399.54M -364.42M
Sales Maturities Of Investments
1.09B 978.22M 863.28M 674.65M 579.63M 504.01M 333.4M 298.8M 258.77M 268.83M 350.38M 341.69M 417.76M 422.52M 389.27M 430.14M 428.77M 440.34M
Other Investing Acitivies
-2.85M -124.82M -23.56M -23.92M -23.87M 98.1M 1.85M 2.22M 2.23M 2.26M -18.49K -808.49K -833.52K -880.18K -1.26M -2.39M -2.34M -2.29M
Investing Cash Flow
-38.6M -208.56M -274.39M -588.56M -335.97M -217.6M -502.52M -74.01M -59.07M -36.1M 206.69M 155.94M 130.9M 84.33M -5.05M -25.5M 29.17M 75.86M
Debt Repayment
n/a n/a n/a n/a 15M 30M 65M 65M 50M 85M 50M 50M 50M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
16.1M 64.28M 317.78M 561.99M 556.38M 514.38M 269.93M 34.67M 32.82M 25.76M 8.07M -341K -334K 552K 1.03M 5.11M 5.46M 5.57M
Financial Cash Flow
37.61M 170M 735.06M 1.2B 1.21B 1.12B 595.12M 379.54M 359.96M 366.14M 313.45M 68.62M 89.72M 104.14M 171.24M 156.36M 135.61M 72.18M
Net Cash Flow
-308.4M -433.87M 5.1M 175.63M 422.4M 509.21M -231.63M 2.71M 23.92M 71.03M 295.28M 10.17M 19.73M -1.92M -17.73M -59.95M -28.33M -22.45M
Free Cash Flow
-308.39M -401.41M -462.03M -438.32M -455.82M -391.12M -325.71M -303.28M -277.13M -259.21M -225.07M -214.69M -201.2M -190.62M -184.13M -190.92M -193.17M -170.55M